VSE knjižnice (vzajemna bibliografsko-kataložna baza podatkov COBIB.SI)
-
Naše izkušnje zdravljenja z azacitidinom pri bolnikih z akutno mieloično levkemijo, kronično mielomonocitno levkemijo in mielodisplastičnim sindromom = Our treatment experience with azacytidine in patients with acute myeloid leukaemia, chronic myelomonocytic leukaemia and myelodysplastic syndromeČernelč, Peter ; Sever, Matjaž, 1976-Background: Azacytidine was recently approved for treatment of adult patients with acute myeloid leukemia (AML) not elegible for intensive chemotherapy, forpatients with chronic myelomonocytic ... leukemia (CMMoL) and myelodysplastic syndromes (MDS). Prior to azacytidine, patients usually received low-dose ara-C, blood transfusions or growth factors with limited success. Here we present a single institution experience of patient treatment with azacytidine.Patients and treatment: From July 2009 to December 2012 we treated48 patients. Twenty patients had AML, nine refractory anemia (RA), eight refractory anemia with excess blasts (RAEB) type 1, eight RAEB type 2 and three had CMMoL. For various reasons, 17 patients received only one cycle of azacytidine: eight with AML, three with RA, three with RAEB-1, one with RAEB-2 and two with CMMoL. Four patients received only two cycles of azacytidine: two with AML, one with RAEB-1 and one with RAEB-2. We used standard protocol of azacytidine 75 mg/m2 s.c. for seven days every 28 days. Treatment results were expected after three to four cycles of azacytidine. Results: Thirty-two patients received three or more cycles of azacytidine. Outof 13 AML patients, seven (54 %) went into remission and six (46 %) failed therapy. Out of seven RA patients, six (86 %) went into remission, one patienthad partial remission and one patient failed therapy. Five (100 %) patients with RAEB-1 as well as two (67 %) patients with RAEB-2 failed therapy. One patient with RAEB-2 had partial remission. Cytogenetic remission was seen only in one patient with RAEB-2. Only one (25 %) patient with CMMoL responded to therapy. Responders decreased their dependance to blood and platelet transfusions after three or four cycles of azacytidine. Conclusions: Azacytidine was succsessful in half of the treated patients with AML, MDS and CMMoL, who received at least three cycles of therapy. Appropriate patient selection for azacytidine treatment is mandatory.Vir: 4. kongres hematologov in transfuziologov Slovenije (Letn. 81, suppl., nov. 2012, str. II-49-II-55)Vrsta gradiva - prispevek na konferenciLeto - 2012Jezik - slovenskiCOBISS.SI-ID - 694700
![loading ... loading ...](themes/default/img/ajax-loading.gif)
vir: 4. kongres hematologov in transfuziologov Slovenije (Letn. 81, suppl., nov. 2012, str. II-49-II-55)
![loading ... loading ...](themes/default/img/ajax-loading.gif)
![loading ... loading ...](themes/default/img/ajax-loading.gif)
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|---|
Černelč, Peter | 07012 |
Sever, Matjaž, 1976- | 24908 |
Vir: Osebne bibliografije
in: SICRIS
Izberite prevzemno mesto:
Prevzem gradiva po pošti
Naslov za dostavo:
Med podatki člana manjka naslov.
Storitev za pridobivanje naslova trenutno ni dostopna, prosimo, poskusite še enkrat.
S klikom na gumb "V redu" boste potrdili zgoraj izbrano prevzemno mesto in dokončali postopek rezervacije.
S klikom na gumb "V redu" boste potrdili zgoraj izbrano prevzemno mesto in naslov za dostavo ter dokončali postopek rezervacije.
S klikom na gumb "V redu" boste potrdili zgoraj izbrani naslov za dostavo in dokončali postopek rezervacije.
Obvestilo
Trenutno je storitev za avtomatsko prijavo in rezervacijo nedostopna. Gradivo lahko rezervirate sami na portalu Biblos ali ponovno poskusite tukaj kasneje.
Gesla v Splošnem geslovniku COBISS
Izbira mesta prevzema
Gradivo iz matične enote je brezplačno. Če je gradivo na mesto prevzema dostavljeno iz drugih enot, lahko knjižnica to storitev zaračuna.
Mesto prevzema | Status gradiva | Rezervacija |
---|
Rezervacija v teku
Prosimo, počakajte trenutek.
Rezervacija je uspela.
Rezervacija ni uspela.
Rezervacija...
Članska izkaznica:
Mesto prevzema: